MicroRNA: Crucial modulator in purinergic signalling involved diseases.
MicroRNA: Crucial modulator in purinergic signalling involved diseases.
复制标题
MicroRNA:嘌呤能信号传导涉及疾病的关键调节剂。
DOI:
10.1007/s11302-022-09840-y
复制
发表时间:
2023-03
影响因子:
3.5
通讯作者:
Yin, Hai-Yan
中科院分区:
文献类型:
--
作者:
Guo, Jing;Yang, Peng;Li, Yi-Fan;Tang, Jin-Fan;He, Zhao-Xuan;Yu, Shu-Guang;Yin, Hai-Yan
关键词:
Both microRNAs (miRNAs) and purinergic signalling are widely and respectively expressed in various tissues of different organisms and play vital roles in a variety of physiological and pathological processes. Here, we reviewed the current publications contributed to the relationship of miRNAs and purinergic signalling in cardiovascular diseases, gastrointestinal diseases, neurological diseases, and ophthalmic diseases. We tried to decode the miRNAs-purinergic signalling network of purinergic signalling involved diseases. The evidence indicated that more than 30 miRNAs (miR-22, miR-30, miR-146, miR-150, miR-155, miR-187, etc.) directly or indirectly modulate P1 receptors (A1, A2A, A2B, A3), P2 receptors (P2X1, P2X3, P2X4, P2X7, P2Y2, P2Y6, P2Y12), and ecto-enzymes (CD39, CD73, ADA2); P2X7 and CD73 could be modulated by multiple miRNAs (P2X7: miR-21, miR-22, miR-30, miR-135a, miR-150, miR-186, miR-187, miR-216b; CD73: miR-141, miR-101, miR-193b, miR-340, miR-187, miR-30, miR-422a); miR-187 would be the common miRNA to modulate P2X7 and CD73.
登录
查看更多内容
影响因子:
9
作者:
通讯作者:
--
影响因子:
3.7
作者:
Feng X;Wang H;Ye S;Guan J;Tan W;Cheng S;Wei G;Wu W;Wu F;Zhou Y
通讯作者:
Zhou Y
影响因子:
19
作者:
Alcedo KP;Bowser JL;Snider NT
通讯作者:
Snider NT
影响因子:
3.5
作者:
Chavda, Seetal;Luthert, Philip J.;Salt, Thomas E.
通讯作者:
Salt, Thomas E.
影响因子:
1.7
作者:
Densmore JC;Schaid TR;Jeziorczak PM;Medhora M;Audi S;Nayak S;Auchampach J;Dwinell MR;Geurts AM;Jacobs ER
通讯作者:
Jacobs ER